Pritumumab (also known in the literature as CLNH11, CLN-IgG, and ACA-11) was the first monoclonal antibody tested in cancer patients. Pritumumab is a natural human monoclonal antibody developed from a B lymphocyte isolated from a regional draining lymph node of a patient with cervical carcinoma.
別名(Alternative names)
CLN G11
靶點;物種(Specificity target name;species)
VIM [Homo sapiens]
種類(Species)
Homo sapiens
受體鑒定(Receptor identification)
IgG1-nd
CAS
499212-74-7
存儲條件(Storage)
Use a manual defrost freezer and avoid repeated freeze-thaw cycles.